In this episode of the Epigenetics Podcast, we talked with Ryan Corces from the Gladstone Institutes about his work on the impact of chromatin architecture on Alzheimer's and Parkinson's Disease. The discussion begins in discussing he start of Dr. Corces research career and he shares his groundbreaking findings in acute myeloid leukemia (AML), demonstrating how mutations occurring in hematopoietic stem cells lead to the evolution of this disease. He emphasizes the pivotal role of epigenetic

In the second episode of the "That Single Patient" Series, Dr. Catherine van Montfrans sits down with Dr. Ana Maria Forsea to share the story of her first melanoma patient, a young mother with stage IV disease, whose resilience and dignity left a lasting impression. From the clinic to the lab, Ana Maria reflects on the lessons she learned about empathy, presence, and truly seeing the patient beyond the disease. This episode highlights how compassionate communication, time, and human connection can

Attorneys are skilled in evaluating evidence for claims and making complex ideas easier to understand, two skills that come in handy when assessing scientific theories as well. Today, Dr. Casey Luskin begins a conversation with attorney and former Colorado House of Representatives member Barry Arrington to discuss the evidence for intelligent design and his new book Unforgetting God. In Part 1 of the conversation, Arrington lays out several key arguments for intelligent design and assesses their

This episode teaches survival in avalanche-prone environments, emphasizing that most avalanches are preventable if warning signs are recognized early. Avalanches often strike without sound or warning, making awareness and preparation more important than strength or speed.Listeners are encouraged to avoid danger before it starts by identifying risky slopes — typically between 30 to 45 degrees, especially when fresh powder sits atop hard ice. Sounds like a deep whumpf beneath the feet signal

This episode of ASEAN MedTech Insights tackles a critical hurdle for global MedTech companies eyeing the Indonesian market: the mandatory appointment of a Local Authorized Representative (LAR). We explore why this is more than a procedural step and how the right partner can make or break your market access strategy.Imagine spending months preparing your technical dossier, only to have your product registration in Indonesia tied to an underperforming distributor. You're losing sales and want to

This episode of MENA MedTech Insights dives into the complexities of entering the region's top markets: Saudi Arabia, the UAE, Egypt, and Israel. We explore the common pitfalls of using separate vendors for each country's unique regulatory hurdles and reveal how a unified market-access strategy can dramatically accelerate growth and reduce costs.We break down how a single-partner approach streamlines everything from initial registration to post-market surveillance. Instead of juggling multiple

I have joined The Nappy Collective as their official Advocate to lead the fight to eliminate the Nappy Crisis in Australia. This Anti-Poverty Week, which runs from October 12 to 18, The Nappy Collective is aiming to raise $10,000 to continue their work supporting families in crisis.On this special episode of The Core Conversation, Sue Karzis, the CEO of The Nappy Collective, joined me to talk about the amazing work her organisation is doing to help families in Australia. Nappies are not luxury items

The CEO of Blueprint (up to the acquisition) discusses the company's success factors, and being led to immunology by the science. Plus, why she believes an oral pill that is disease modifying, like Fulcrum is trying to develop, is strongly needed for the sickle cell patient community.

Just Add a Zero: Remove the Film, Outperform your Competition, and Grow Exponentially through CollaborationNow aUSA TodayFeatured Bestseller!What if you could add a zero?If you had the ability to add a zero to any area of your life, where would you place it? Time? Family? Money? Health? The truth is, you’re much closer to that reality than any other time in history.The world has changed. Competition used to define the marketplace, separating winners from losers in a cut throat game of money making

Marissa HeiselDr. Marissa - a passionate advocate for transformational wellnessWith over 25 years of expertise, Dr. Marissa embodies her motto, “You are your own best medicine,” guiding women—and anyone seeking renewal—on a journey of self-discovery and consciousness.Her unique blend of chiropractic care, midwifery, and child development experience fuels a practice rooted in natural healing modalities like bioenergetic healing, essential oils, nutrition, herbalism, and integrative health. She’s

In this episode of 'A Shot in The Arm Podcast,' host Ben Plumley reconnects with his longtime friend and colleague, Andy Seale from the World Health Organization. The conversation spans decades of their personal and professional journeys across global health, with a primary focus on HIV, TB, and malaria. Ben and Andy discuss the challenges and triumphs of their work, including Andy's experience with HIV diagnosis and the global fight against pandemics such as Ebola. They also tackle critical issues

He walks us through the design, build, test, learn model that is the foundation of Generate's approach to drug development.

"Sweden has been ranked the European Union's innovation leader for the fifth or sixth year in a row, and we're second globally. We have 4,000 life science companies—a remarkably high number for a country of 10 million people."Dr Marjo Puumalainen, International Director of SwedenBIO, brings extensive life science experience from both startup environments and academic research. Having previously served as Chief Scientific Officer at a CRISPR-based antivirals startup and completed

In our continuing look at advanced manufacturing in healthcare, this episode explores how 3D printing is transforming the design and production of medical devices. My guest today is Atul Dhall, Engineering Consultant at TransAtlantic Science. He will talk to us about the benefits of creating custom implants, prosthetics, and surgical tools tailored to individual patients, as well as the ability to quickly prototype new devices for testing and development.

Ever wondered about life with Crohn's disease? Join us as we speak with social media influencer Paula Sojo (@paulasojoro). She shares her personal journey and insights.Topics Covered: Intro Describe Your Journey with Crohn’s Disease Paula discusses her personal experience living with Crohn’s disease. Why do you think this condition is so often misdiagnosed? We explore the challenges in diagnosing Crohn’s disease. How do you mentally cope with Crohn’s disease? Mental strategies and tips for dealing

In this episode, we explore how outdated programming—both in our minds and in our machines—keeps us looping through the same experiences. From the echo chambers of social media to the feedback loops in our own thoughts, Old Algorithms & New Timelines uncovers how science, spirituality, and technology intertwine in the way we perceive time and reality.Host Ashlei breaks down how algorithms mirror human cognition, how quantum physics explains timeline “shifts,” and why awareness is the ultimate

He welcomes us to Benchtalk 2025, which had more than 800 scientists register this year, and describes how AI and other computational advances are allowing scientists to focus on increasing the speed and reducing the cost of R&D.

In today’s Pharmaceutical Executive Daily, we explore Johnson & Johnson’s plan to separate its orthopaedics division into a standalone company, the global implications of the Most Favored Nation drug pricing proposal, and strategies helping small biotechs reach market faster.

He describes the science behind FORCE, which combines an antigen-binding fragment, a linker and, a payload. The company's DMD program will have a key trial readout before the end of this year, and DM1 will follow in 2026. Both programs could be filed for AA in 2026 with positive data.